Today: 8 February 2026
Subscribe

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

Amgen stock slips to $330 as year-end pullback hits Wall Street; Fed minutes and MariTide updates in focus

NEW YORK, December 29, 2025, 22:14 ET — Market closed Amgen shares fell 1% on Monday, ending the session down $3.30 at $329.63. StockAnalysis The decline matters now because traders are heading into the final sessions of the year with U.S. indexes near record territory and liquidity thinner than usual. That backdrop can amplify moves in large-cap healthcare stocks even without a company-specific trigger. Reuters Wall Street’s main indexes closed lower, led by a retreat in heavyweight technology names, Reuters reported. “It’ll turn out to be a buying opportunity,” said Hank Smith, director and head of investment strategy at Haverford
30 December 2025
···
BlackRock stock today: BLK barely higher as Wall Street slips; Fed minutes and data loom

BlackRock stock today: BLK barely higher as Wall Street slips; Fed minutes and data loom

NEW YORK, December 29, 2025, 22:07 ET — Market closed BlackRock Inc shares edged up on Monday, ending nearly flat at $1,088.40 as Wall Street turned lower in holiday-thinned trading. Reuters For BlackRock, modest moves in markets matter because they feed directly into assets under management (AUM) — the pool of client money it charges fees on. The firm oversees more than $13 trillion, Reuters has reported. Reuters That sensitivity is in sharper focus into year-end, as traders re-price the interest-rate outlook ahead of the Federal Reserve’s December meeting minutes due on Tuesday. Shifts in rate expectations can swing risk
30 December 2025
·
Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed pitches made-in-India C-130J Super Hercules line as IAF weighs 80-plane transport buy

Lockheed Martin has offered to set up a C-130J Super Hercules final-assembly line in India as it competes for a contract to supply up to 80 military transport aircraft. India is the only location outside the U.S. under consideration for C-130J co-production, a Lockheed executive said. Rival bids include Embraer and Airbus. Some Indian media report the air force has dropped plans for more C-130Js and is focusing on a new medium transport aircraft program.
30 December 2025
·
Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol stock slips in year-end tech pullback; Fed minutes and housing data loom

Amphenol shares closed down 0.4% at $136.90 Monday as tech stocks dragged U.S. markets lower in thin year-end trading. The stock traded between $135.83 and $137.59 on volume of 4.3 million shares. Amphenol will report fourth-quarter results on Jan. 28. Investors are watching upcoming U.S. economic data and Federal Reserve minutes for further direction.
30 December 2025
·······
AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

AMAT stock ends higher in thin year-end trade as tech slips — what investors are watching next

NEW YORK, December 29, 2025, 10:00 PM ET — Market closed Applied Materials shares ended Monday up 0.44% at $263.05, near the top of their 52-week range, after a session that saw the broader market retreat from recent highs. The stock traded between $260.00 and $264.65 on the day. Google The chip-equipment maker is closely watched because its orders tend to track wafer fab equipment spending — the big-ticket tools chipmakers buy to manufacture semiconductors. With 2025 winding down, traders have been calibrating expectations for 2026 capital spending as AI-linked demand lifts parts of the supply chain, while tighter export
30 December 2025
·
Society Pass (SOPA) stock jumps 61% after TikTok Shop live-commerce launch in Thailand

Society Pass (SOPA) stock jumps 61% after TikTok Shop live-commerce launch in Thailand

Society Pass shares soared 61% to $2.93 on volume of 153 million after launching a TikTok Shop live-commerce platform in Thailand. The stock traded between $2.21 and $3.46, far above typical activity. Executives set a $10 million revenue target for the new business line in 2026. Traders are watching for early traction and updates on earnings.
30 December 2025
···
CrowdStrike stock slips as CEO George Kurtz gets new performance award tied to $20B ARR goal

CrowdStrike stock slips as CEO George Kurtz gets new performance award tied to $20B ARR goal

CrowdStrike disclosed a new performance-based equity award for CEO George Kurtz, potentially delivering up to 600,000 shares if the stock outperforms most of the S&P 500 over three years, according to an SEC filing. Shares closed down 1.1% at $475.91 on Monday. Chief Accounting Officer Anurag Saha sold 836 shares at $476.83 on Dec. 24. Investors await Fed minutes as holiday trading thins.
30 December 2025
··
Target stock drops after activist buzz fades; Fed minutes set the next test for TGT

Target stock drops after activist buzz fades; Fed minutes set the next test for TGT

Target fell 1.4% to $98.10 Monday, erasing part of last week’s activist-driven gains as trading volume stayed light. The move followed news that Toms Capital took a significant but undisclosed stake. Investors await Tuesday’s Fed minutes and any updates from the activist investor. Target has no investor events scheduled before its next earnings report, expected in early March.
30 December 2025
·····
AT&T stock ends higher as Wall Street slips into year-end; traders eye Jan. 28 earnings

AT&T stock ends higher as Wall Street slips into year-end; traders eye Jan. 28 earnings

NEW YORK, December 29, 2025, 21:32 ET — Market closed AT&T Inc. shares ended Monday up 0.5% at $24.77, a modest gain that stood out as Wall Street’s major indexes finished lower to start the final trading week of the year. FinancialContent The move matters because markets are entering a holiday-shortened stretch with thinner liquidity, a setup that can amplify sector rotations and late-year positioning. For AT&T, the calendar adds pressure of its own: investors are already looking toward the company’s Jan. 28 earnings report for a read on wireless and fiber momentum and on cash generation that supports dividends
30 December 2025
··
Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Synopsys stock closes higher as traders eye Dec. 30 lawsuit deadline and Fed minutes

Synopsys shares rose 0.4% to $478.97 Monday, outperforming the Nasdaq as broader markets slipped in thin year-end trading. Investor-law firms reminded shareholders of a Dec. 30 deadline in a securities class-action case tied to alleged misstatements in the company’s Design IP business. About 1.33 million Synopsys shares traded, with the stock moving between $471.28 and $484.33.
30 December 2025
··
Mastercard stock slips with payments peers as year-end trading thins; MA eyes Fed minutes

Mastercard stock slips with payments peers as year-end trading thins; MA eyes Fed minutes

NEW YORK, December 29, 2025, 21:31 ET — Market closed Mastercard Inc shares fell 0.3% to $577.90 on Monday, after trading between $577.01 and $581.99. The move mattered because year-end liquidity is thinning, amplifying small shifts in risk appetite across large-cap stocks. Investors also start repositioning for January, when macro data and central bank signals typically regain control of price action. For payments stocks, the rate outlook has become a near-term driver. Expectations for 2026 policy easing can support spending and travel volumes that generate fees for card networks, while higher yields can pressure equity valuations. Wall Street’s main indexes
30 December 2025
··
MercadoLibre (MELI) stock price today: Shares edge higher into Fed minutes as year-end trading thins

MercadoLibre (MELI) stock price today: Shares edge higher into Fed minutes as year-end trading thins

MercadoLibre shares closed up 0.4% at $2,014.97 on Monday, outperforming declines in major U.S. indexes. The stock traded between $1,986 and $2,037 during the session. Traders are awaiting Federal Reserve meeting minutes Tuesday and a holiday-shifted jobless claims report Wednesday. MercadoLibre’s next scheduled earnings release is set for late February.
30 December 2025
·
KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

KLA stock drops after tech pullback hits chip equipment names; Fed minutes next

NEW YORK, December 29, 2025, 21:14 ET — Market closed KLA Corp shares fell on Monday, snapping a six-session winning streak, as a pullback in heavyweight technology stocks spilled into chip-linked names. MarketWatch+1 The move matters now because chip equipment makers like KLA sit early in the semiconductor supply chain, and their shares often track shifts in investor appetite for the tech trade. Year-end positioning can exaggerate those swings when liquidity is thin. Reuters+1 Wall Street started the holiday-shortened week on a softer note after last week’s rally, with the Nasdaq down 0.5% and the S&P 500 off 0.35%, Reuters
30 December 2025
······
1 … 671 672 673 674 675 … 1,636

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Go toTop